Charles A. Deignan's most recent trade in Clearside Biomedical Inc was a trade of 200,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 18, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Clearside Biomedical Inc | A. Deignan Charles | Chief Financial Officer | 18 Jan 2024 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | ||
Clearside Biomedical Inc | Deignan Charles A. | Chief Financial Officer | 18 Jan 2024 | 12,900 | 384,662 (0%) | 0% | 1.3 | 16,512 | Common Stock | |
Clearside Biomedical Inc | Charles A. Deignan | Chief Financial Officer | 04 Jan 2023 | 187,500 | 187,500 | - | - | Employee Stock Option (right to buy) | ||
Clearside Biomedical Inc | Charles A. Deignan | Chief Financial Officer | 20 Dec 2022 | 23,636 | 0 | - | - | Employee Stock Option (right to buy) | ||
Clearside Biomedical Inc | Charles A. Deignan | Chief Financial Officer | 20 Dec 2022 | 23,636 | 377,502 (0%) | 0% | 0.4 | 9,454 | Common Stock | |
Clearside Biomedical Inc | Charles A. Deignan | Chief Financial Officer | 18 Jan 2022 | 138,750 | 138,750 | - | - | Stock Option (Right to Buy) | ||
Clearside Biomedical Inc | Charles A. Deignan | Chief Financial Officer | 18 Jan 2022 | 46,250 | 362,699 (0%) | 0% | 0 | Common Stock | ||
Clearside Biomedical Inc | Charles A. Deignan | Chief Financial Officer | 21 Sep 2021 | 2,800 | 316,449 (0%) | 0% | 6.4 | 17,948 | Common Stock | |
Clearside Biomedical Inc | Charles A. Deignan | Chief Financial Officer | 21 Jun 2021 | 2,938 | 319,249 (0%) | 0% | 4.4 | 12,839 | Common Stock | |
Clearside Biomedical Inc | Charles A. Deignan | Chief Financial Officer | 18 Jan 2021 | 195,640 | 195,640 | - | - | Stock Option (Right to Buy) | ||
Clearside Biomedical Inc | Charles A. Deignan | Chief Financial Officer | 18 Jan 2021 | 96,360 | 322,187 (0%) | 0% | 0 | Common Stock |